Oudemansiella radicata protein extract and anti-tumor application thereof
A technology of protein extract and rhizome mushroom, applied in the direction of antineoplastic drugs, peptide/protein components, applications, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Embodiment 1, the preparation of root mushroom protein extract
[0033] 1. Preparation of the fruiting body of Rhizome Mushroom
[0034] Inoculate the slant strain of Oudemansiella radicata CFCC89567 into the primary medium for activation, culture at a constant temperature of 25°C, and inoculate it into the secondary medium after the mycelium is full of the test tube, and cultivate at a constant temperature of 25°C Cultivate in the room until the mycelium is full, inoculate the secondary species into the cultivation bag with the cultivation medium at 25°C for fungal growth, and then scratch the fungus after the fungus is full of the cultivation bag and move it into the greenhouse. The fruiting conditions Keep the humidity above 90% and the temperature at 17-28°C, collect the first tide fruiting body, and obtain the fruiting body of Oudemansiella radicata CFCC89567.
[0035] Wherein, the culture medium used in this experiment is as follows:
[0036] Primary seed medium...
Embodiment 2
[0043] Example 2, Rhizome Rhizome Protein Extract Inhibits Tumor Cell Proliferation Experiment
[0044] 1.1 Tested cell lines
[0045] Human liver cancer HepG2 cells (purchased from ATCC, USA), human breast cancer MCF-7 cells (purchased from ATCC, USA) and human lung adenocarcinoma A-549 cells (purchased from ATCC, USA).
[0046] 1.2 Experimental method
[0047] 1.2.1 Cell lines and cell culture
[0048] Human liver cancer HepG2 cells, human breast cancer MCF-7 cells and human lung adenocarcinoma A-549 cells were activated and passaged according to conventional culture methods. Among them, the subculture and activation medium of human liver cancer HepG2 cells is DMEM-high glucose + 1% double antibody + 10% FBS (in DMEM-high glucose (Hyclone, SH30022.01B) a mixture of penicillin and streptomycin (penicillin 10000U / mL, streptomycin 10000μg / mL) and fetal bovine serum (FBS, Hyclone, SV30087.02), so that the final volume percentage of the former two is 1%, and the volume percent...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com